Susan Gray
Overview
Explore the profile of Susan Gray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Robinson H, Atkin L, Gray S
Br J Nurs
. 2023 Nov;
32(Sup20):S30-S38.
PMID: 37949495
The use of compression therapy is known to be effective in the management of patients with venous leg ulceration and is commonly recommended as a first-line treatment. A rare but...
2.
Bell K, Shaw J, Maple-Brown L, Ferris W, Gray S, Murfet G, et al.
Diabetes Res Clin Pract
. 2020 May;
164:108188.
PMID: 32360708
Prediabetes has a high prevalence, with early detection essential to facilitate optimal management to prevent the development of conditions such as type 2 diabetes and cardiovascular disease. Prediabetes can include...
3.
Flavin M, Shore B, Miller P, Gray S
J Adolesc Health
. 2019 Jun;
65(3):405-409.
PMID: 31248805
Purpose: The purpose of the study was to describe the prevalence and patterns of prescription of hormonal contraceptive medications to young women with cerebral palsy (CP) and determine if CP...
4.
Sibley L, Gooch K, Wareham A, Gray S, Chancellor A, Dowall S, et al.
Sci Rep
. 2019 Mar;
9(1):3340.
PMID: 30833652
Monocyte:lymphocyte ratio (M:L) has been identified as a risk factor in development of TB disease in children and those undergoing treatment for HIV in co-infected individuals. Retrospective analysis was performed...
5.
Ford E, Gray S, Subedi B
Acad Psychiatry
. 2017 Apr;
41(6):783-788.
PMID: 28424982
No abstract available.
6.
Asrafuzzaman M, Cao Y, Afroz R, Kamato D, Gray S, Little P
Biomed Pharmacother
. 2017 Mar;
89:1242-1251.
PMID: 28320091
Type 2 diabetes mellitus is a complex and heterogeneous disorder which in its most common manifestation arises from insulin resistance and later insulin insufficiency. Type 2 diabetes is characterised by...
7.
Jung D, Chalasani U, Pan N, Friedline R, Prosdocimo D, Nam M, et al.
PLoS One
. 2013 Oct;
8(10):e77851.
PMID: 24167585
Obesity places major demands on the protein folding capacity of the endoplasmic reticulum (ER), resulting in ER stress, a condition that promotes hepatic insulin resistance and steatosis. Here we identify...
8.
Nagata N, Matsuo K, Bettaieb A, Bakke J, Matsuo I, Graham J, et al.
Endocrinology
. 2012 May;
153(7):3158-69.
PMID: 22619361
The Src homology 2 domain-containing protein-tyrosine phosphatase Src homology phosphatase 2 (Shp2) is a negative regulator of hepatic insulin action in mice fed regular chow. To investigate the role of...
9.
Gray S, Kim J
Trends Endocrinol Metab
. 2011 Jun;
22(10):394-403.
PMID: 21680199
Insulin resistance is a major characteristic of obesity and type 2 diabetes, and develops in multiple organs, including the heart. Compared with its role in other organs, the physiological role...
10.
Gao X, Huang L, Grosjean F, Esposito V, Wu J, Fu L, et al.
Kidney Int
. 2011 Jan;
79(9):987-96.
PMID: 21248717
Dietary protein restriction is an important treatment for chronic kidney disease. Herein, we tested the effect of low-protein or low-protein plus ketoacids (KA) diet in a remnant kidney model. Rats...